Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析

◆英語タイトル:Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH406158FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Vaxart Inc (VXRT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vaxart Inc (Vaxart), formerly Aviragen Therapeutics Inc, is a clinical-stage pharmaceutical company that develops oral recombinant vaccines based on its proprietary oral vaccine platform, which uses state-of-the-art recombinant technology. The platform enables the company to develop oral versions of currently available vaccines, and design recombinant vaccines for new indications. Vaxart is developing prophylactic vaccine candidates for a range of infectious diseases, including norovirus infection, seasonal influenza, respiratory syncytial virus (RSV) infection, and coronavirus (COVID-19) disease. The company is also developing a therapeutic immune-oncology vaccine, which targets cervical cancer, and dysplasia caused by human papillomavirus (HPV). Vaxart is headquartered in San Francisco, California, the US.

Vaxart Inc Key Recent Developments

Feb 25,2021: Vaxart provides business update and reports fourth quarter and full year 2020 financial results
Jan 28,2021: Vaxart announces resignation of Steven Boyd and Keith Maher
Nov 12,2020: Vaxart reports third quarter 2020 financial results and provides business update
Oct 07,2020: Centaur Biopharmaceutical services announces expansion of manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates
Sep 25,2020: VAXART investigation initiated by Former Louisiana Attorney General: Kahn Swick & Foti investigates the officers and directors of Vaxart – VXRT

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Vaxart Inc – Key Facts
Vaxart Inc – Key Employees
Vaxart Inc – Key Employee Biographies
Vaxart Inc – Major Products and Services
Vaxart Inc – History
Vaxart Inc – Company Statement
Vaxart Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vaxart Inc – Business Description
Vaxart Inc – Corporate Strategy
Vaxart Inc – SWOT Analysis
SWOT Analysis – Overview
Vaxart Inc – Strengths
Vaxart Inc – Weaknesses
Vaxart Inc – Opportunities
Vaxart Inc – Threats
Vaxart Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Vaxart Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2021: Vaxart provides business update and reports fourth quarter and full year 2020 financial results
Jan 28, 2021: Vaxart announces resignation of Steven Boyd and Keith Maher
Nov 12, 2020: Vaxart reports third quarter 2020 financial results and provides business update
Oct 07, 2020: Centaur Biopharmaceutical services announces expansion of manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates
Sep 25, 2020: VAXART investigation initiated by Former Louisiana Attorney General: Kahn Swick & Foti investigates the officers and directors of Vaxart – VXRT
Aug 27, 2020: Vaxart appoints Karen J. Wilson to its Board of Directors
Aug 06, 2020: Vaxart announces second quarter 2020 results
Jul 16, 2020: Norovirus gastroenteritis costs an estimated $10.6 Billion each year in the United States
Jul 13, 2020: Second Virus Wave fears create growing demand for testing, treatments and vaccine candidates
Jun 25, 2020: Vaxart signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Vaxart Inc, Key Facts
Vaxart Inc, Key Employees
Vaxart Inc, Key Employee Biographies
Vaxart Inc, Major Products and Services
Vaxart Inc, History
Vaxart Inc, Subsidiaries
Vaxart Inc, Key Competitors
Vaxart Inc, Annual Ratios
Vaxart Inc, Annual Ratios (Cont...1)
Vaxart Inc, Interim Ratios
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Vaxart Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Vaxart Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Central National-Gottesman Inc.:企業の戦略・SWOT・財務情報
    Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report Summary Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Symic Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops new therapeutics focused on matrix biology. The company’s pipeline products include SB-030 and SB-061. Its SB-030 is a clinical candidate used for the prevention of peripheral vascular diseases or vein graft …
  • Hite Jinro Co., Ltd:企業の戦略・SWOT・財務分析
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Advanced Biological Laboratories SA-医療機器分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • Novacyt SA (ALNOV):企業の財務・戦略的SWOT分析
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Bonavista Energy Corp (BNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonavista Energy Corp (Bonavista) is an intermediate energy company, which acquires, explores for, develops and produces oil and natural gas from its assets in the provinces of Alberta, British Columbia and Saskatchewan. Its core operations are concentrated in the Glauconite and Falher plays …
  • Emerson Electric Co (EMR)-エネルギー分野:企業M&A・提携分析
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Alabama Municipal Electric Authority:企業の発電所・SWOT分析2018
    Alabama Municipal Electric Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Centogene AG-医療機器分野:企業M&A・提携分析
    Summary Centogene AG (Centogene) is a provider of genetic testing services. The company offers genetic testing for rare hereditary disorders. It offers whole genome sequencing, whole exome sequencing, biomarker and biochemical testing; prenatal testing, DNA extraction and cell culture services. Cent …
  • Metropolitan Health Networks Inc-製薬・医療分野:企業M&A・提携分析
    Summary Metropolitan Health Networks Inc (MHN) a subsidiary of Humana Inc is a healthcare organization that offers primary care services. The organization operates through a network of doctors, nurses and specialists for seniors insured through Medicare. It provides service through provider service …
  • Luna Innovations Inc (LUNA):企業の財務・戦略的SWOT分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …
  • Forty Seven Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • Calfrac Well Services Ltd (CFW):石油・ガス:M&Aディール及び事業提携情報
    Summary Calfrac Well Services Ltd (Calfrac) is an oilfield services company. It operates as an independent provider of specialized oilfield services. The company offers various specialized services such as hydraulic fracture-stimulation, coiled tubing, well simulation, fracturing, acidizing, frac de …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Arris International Plc
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kapsch TrafficCom AG (KTCG):企業の財務・戦略的SWOT分析
    Kapsch TrafficCom AG (KTCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cancer Research Technology Ltd-医療機器分野:企業M&A・提携分析
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • Primordial Genetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Primordial Genetics Inc (Primordial Genetics) is a biotechnology company that provides genetic and synthetic biology solutions for protein engineering and microbial improvement. The company develops improved bacterial and yeast strains for commercial protein production and protein expression …
  • Pakistan Refinery Ltd (PRL):企業の財務・戦略的SWOT分析
    Pakistan Refinery Ltd (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Admedus Ltd (AHZ):製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆